Nebenwirkungen · Erbitux
Erbitux 5 mg/mL solution for infusion · Abschnitt 4.8 · PDF-Seite 13
HOS-113186 · Präparat HOS-093871
In combination with local radiation therapy of the head and neck area, additional undesirable effects were those typical of radiation therapy (such as mucositis, radiation dermatitis, dysphagia or leukopenia, mainly presenting as lymphocytopenia). In a randomised controlled clinical study with 424 patients, reporting rates of severe acute radiation dermatitis and mucositis as well as of late radiation-therapy-related events were slightly higher in patients receiving radiation therapy in combination with cetuximab than in those receiving radiation therapy alone.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-15T11:55:00Z · SHA-256 073f5effd93351048ad74afee3f940b1c0ad5d24722452304a7b761a65e30f20 · Passage 3f355f5c96df82e18618f0b6973cf136222b2ec6d59a269f5bc74bc4ef4845cc · Zeichen 13821–14388 im Abschnitt